A head-to-head trial comparing secukinumab (Cosentyx) versus adalimumab (Humira) for the treatment of ankylosing spondylitis.
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Secukinumab (Primary) ; Adalimumab
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 14 Jun 2016 New trial record